» Articles » PMID: 7706296

Epiregulin. A Novel Epidermal Growth Factor with Mitogenic Activity for Rat Primary Hepatocytes

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Mar 31
PMID 7706296
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Epiregulin, a novel epidermal growth factor (EGF)-related growth regulating peptide, was purified from conditioned medium of the mouse fibroblast-derived tumor cell line NIH3T3/clone T7. It was a 46-amino-acid single chain polypeptide, and its amino acid sequence exhibited 24-50% amino acid sequence identity with sequences of other EGF-related growth factors. Epiregulin exhibited bifunctional regulatory properties: it inhibited the growth of several epithelial tumor cells and stimulated the growth of fibroblasts and various other types of cells. Epiregulin bound to the EGF receptors of epidermoid carcinoma A431 cells much more weakly than did EGF, but was nevertheless much more potent than EGF as a mitogen for rat primary hepatocytes and Balb/c 3T3 A31 fibroblasts. These findings suggest that epiregulin plays important roles in regulating the growth of epithelial cells and fibroblasts by binding to receptors for EGF-related ligands.

Citing Articles

A Conjugate of an EGFR-Binding Peptide and Doxorubicin Shows Selective Toxicity to Triple-Negative Breast Cancer Cells.

Than P, Yao S, Althagafi E, Kaur K ACS Med Chem Lett. 2025; 16(1):109-115.

PMID: 39811122 PMC: 11726362. DOI: 10.1021/acsmedchemlett.4c00480.


The epidermal growth factor receptor inhibitor gefitinib enhances in vitro and in vivo sensory axon regeneration and functional recovery following transection in a mouse median nerve injury model.

Topley M, Sparks P, Crotty A, Kawaja M, Hendry J Muscle Nerve. 2024; 71(1):113-123.

PMID: 39529451 PMC: 11632577. DOI: 10.1002/mus.28291.


Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma.

Xu S, Wang H, Zhu Y, Han Y, Liu L, Zhang X Int J Oral Sci. 2024; 16(1):47.

PMID: 38945975 PMC: 11214941. DOI: 10.1038/s41368-024-00311-1.


Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment.

Kubo T, Nishimura N, Kaji K, Tomooka F, Shibamoto A, Iwai S Int J Mol Sci. 2024; 25(8).

PMID: 38673992 PMC: 11050651. DOI: 10.3390/ijms25084405.


The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.

ONeill C, Sun K, Sundararaman S, Chang J, Glynn S Front Physiol. 2024; 15:1358850.

PMID: 38601214 PMC: 11004480. DOI: 10.3389/fphys.2024.1358850.